We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 81-100 of 10,000 results
  1. Macrophages as tools and targets in cancer therapy

    Tumour-associated macrophages are an essential component of the tumour microenvironment and have a role in the orchestration of angiogenesis,...

    Alberto Mantovani, Paola Allavena, ... Cecilia Garlanda in Nature Reviews Drug Discovery
    Article 16 August 2022
  2. Adoptive neoantigen-reactive T cell therapy: improvement strategies and current clinical researches

    Neoantigens generated by non-synonymous mutations of tumor genes can induce activation of neoantigen-reactive T (NRT) cells which have the ability to...

    Ruichen Huang, Bi Zhao, ... Wei Zhang in Biomarker Research
    Article Open access 17 April 2023
  3. TCR Signals Controlling Adaptive Immunity against Toxoplasma and Cancer

    T cells play a crucial role in adaptive immunity by recognizing and eliminating foreign pathogens and abnormal cells such as cancer cells. T cell...
    Masaaki Okamoto, Masahiro Yamamoto in Basic Immunology and Its Clinical Application
    Chapter 2024
  4. Donor T cells for CAR T cell therapy

    Adoptive cell therapy using patient-derived chimeric receptor antigen (CAR) T cells redirected against tumor cells has shown remarkable success in...

    Tiffany C. Y. Tang, Ning Xu, ... Alla Dolnikov in Biomarker Research
    Article Open access 01 April 2022
  5. Interleukin 1β receptor blocker (Anakinra) and regenerative stem cell therapy: two novel approaches effectively ameliorating diabetic cardiomyopathy

    Diabetic cardiomyopathy (DCM) is a serious common complication of diabetes. Unfortunately, there is no satisfied treatment for those patients and...

    Lamiaa Mohamed Mahmoud, Aya Aly Ashraf Abdel Mageed, ... Hania Ibrahim Ammar in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 22 May 2024
  6. Non–small cell lung cancer and immune checkpoint inhibitor therapy: does non-alcoholic fatty liver disease have an effect?

    Background

    Immunotherapy based on the application of immune checkpoint inhibitors (ICIs) is one of the standard treatments for advanced non-small cell...

    Yi Li, Bingxin Gong, ... Guofeng Zhou in BMC Cancer
    Article Open access 27 April 2024
  7. Harnessing cancer stem cell-derived exosomes to improve cancer therapy

    Cancer stem cells (CSCs) are the key “seeds” for tumor initiation and development, metastasis, and recurrence. Because of the function of CSCs in...

    Article Open access 23 May 2023
  8. Systemic Onco-sphere: Host Adaptive Immune System

    When antigenic tumor cells contact the immune system, they set off both innate and adaptive immune system. In the previous chapter, we have described...
    Phei Er Saw, Erwei Song in Tumor Ecosystem
    Chapter 2023
  9. Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment

    As a nontraditional T-cell subgroup, γδT cells have gained popularity in the field of immunotherapy in recent years. They have extraordinary...

    Zhifei Gao, Yifeng Bai, ... Peng Luo in Molecular Cancer
    Article Open access 15 February 2023
  10. The Significance of Biomaterials in Stem Cell-Based Regenerative Medicine

    Introduction: Stem cell-based therapeutic strategies have shown tremendous potential in attenuating tissue damage and facilitating tissue repair and...
    Meina Liu, Kai Pan, ... Zong** Li in Regenerative Medicine and Brain Repair
    Chapter 2024
  11. Rapid Screening of CAR T Cell Functional Improvement Strategies by Highly Multiplexed Single-Cell Secretomics

    The functional fitness of CAR T cells plays a crucial role in determining their clinical efficacy. Several strategies are being explored to increase...
    Dragana Slavkovic-Lukic, Jessica Fioravanti, ... Luca Gattinoni in Cancer Immunotherapy
    Protocol 2024
  12. Chemokines in Cancer Therapy

    Chemokines are small cell signalling proteins corresponding to family of cytokines that aid in movement of leukocytes. They are low-molecular-weight...
    Manzoor Ahmad Mir, Iqra Noor in Cytokine and Chemokine Networks in Cancer
    Chapter 2023
  13. Gene Therapy and Cardiovascular Diseases

    Cardiovascular diseases (CVDs) are the leading causes of death globally and urgently require new novel therapeutic strategies. Gene therapy is the...
    Dongchao Lu, Sarah Cushman, ... Christian Bär in Genome Editing in Cardiovascular and Metabolic Diseases
    Chapter 2023
  14. Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results

    Although pembrolizumab confers clinical benefit in non-small cell lung cancer (NSCLC), only a subset of patients will respond due to a heterogenous...

    Martin Gutierrez, Wei-Sen Lam, ... Roy S. Herbst in Nature Medicine
    Article 10 July 2023
  15. Ionizing radiations induce shared epigenomic signatures unraveling adaptive mechanisms of cancerous cell lines with or without methionine dependency

    Background

    Although radiation therapy represents a core cancer treatment modality, its efficacy is hampered by radioresistance. The effect of ionizing...

    Youssef Siblini, Céline Chéry, ... Abderrahim Oussalah in Clinical Epigenetics
    Article Open access 01 December 2021
  16. A prospective study of HER3 expression pre and post neoadjuvant therapy of different breast cancer subtypes: implications for HER3 imaging therapy guidance

    Purpose

    HER3, a member of the EGFR receptor family, plays a central role in driving oncogenic cell proliferation in breast cancer. Novel HER3...

    Nicoleta Sinevici, Christine E. Edmonds, ... Umar Mahmood in Breast Cancer Research
    Article Open access 29 June 2024
  17. Mesenchymal Stromal Cell Therapy Alleviates Ovalbumin-Induced Chronic Airway Remodeling by Suppressing M2 Macrophage Polarization

    Chronic asthma is characterized by airway hyperresponsiveness, inflammation, and remodeling. Previous studies have shown that mesenchymal...

    Haiyang Yu, Guiyin Zhu, ... Wen Gu in Inflammation
    Article 06 February 2024
  18. Resistance of HNSCC cell models to pan-FGFR inhibition depends on the EMT phenotype associating with clinical outcome

    Background

    Focal adhesion signaling involving receptor tyrosine kinases (RTK) and integrins co-controls cancer cell survival and therapy resistance....

    Felix Broghammer, Irina Korovina, ... Nils Cordes in Molecular Cancer
    Article Open access 21 February 2024
  19. Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy

    Hepatocellular carcinoma is the most prevalent form of primary liver cancer with a multifactorial aetiology comprising genetic, environmental, and...

    Amir Ajoolabady, Daolin Tang, ... Jun Ren in British Journal of Cancer
    Article 13 October 2022
  20. Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease

    Autoimmune liver diseases (AILD) include autoimmune hepatitis (AIH), primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC)....

    N. Richardson, G. E. Wootton, ... Y. H. Oo in Seminars in Immunopathology
    Article Open access 31 May 2022
Did you find what you were looking for? Share feedback.